RCWM
VRTX icon

Royal Capital Wealth Management’s Vertex Pharmaceuticals VRTX Stock Holding History

Royal Capital Wealth Management’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-429
Closed -$201K – 98
2024
Q2 		$201K Buy
+429
New +$186K 0.15% 88
2024
Q1 		– Sell
-1,002
Closed -$408K – 99
2023
Q4 		$408K Sell
1,002
-15
-1% -$5.54K 0.35% 53
2023
Q3 		$354K Sell
1,017
-38
-4% -$13.3K 0.34% 56
2023
Q2 		$371K Hold
1,055
– – 0.35% 56
2023
Q1 		$332K Sell
1,055
-24
-2% -$7.2K 0.33% 63
2022
Q4 		$312K Hold
1,079
– – 0.33% 62
2022
Q3 		$312K Hold
1,079
– – 0.36% 62
2022
Q2 		$304K Hold
1,079
– – 0.33% 67
2022
Q1 		$282K Sell
1,079
-6
-0.6% -$1.42K 0.28% 79
2021
Q4 		$238K Buy
+1,085
New +$211K 0.23% 88

Other funds holding VRTX

Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return